|
NDUFS8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78640000000541E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06999999996516E-06 |
| Normal-vs-Stage2 |
9.665700E-02 |
| Normal-vs-Stage3 |
4.742000E-01 |
| Normal-vs-Stage4 |
4.601200E-01 |
| Stage1-vs-Stage2 |
6.066200E-02 |
| Stage1-vs-Stage3 |
3.684000E-03 |
| Stage1-vs-Stage4 |
3.072200E-01 |
| Stage2-vs-Stage3 |
4.026200E-01 |
| Stage2-vs-Stage4 |
8.795600E-01 |
| Stage3-vs-Stage4 |
6.648600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.638230E-04 |
| Normal-vs-AfricanAmerican |
2.815100E-03 |
| Normal-vs-Asian |
5.685600E-01 |
| Caucasian-vs-AfricanAmerican |
4.589600E-01 |
| Caucasian-vs-Asian |
8.181600E-01 |
| AfricanAmerican-vs-Asian |
6.818600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53840000000272E-05 |
| Normal-vs-Female |
1.744320E-02 |
| Male-vs-Female |
7.685400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.263300E-03 |
| Normal-vs-Extreme_Weight |
1.89995999999581E-05 |
| Normal-vs-Obese |
3.330100E-02 |
| Normal-vs-Extreme_Obese |
1.172810E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.102200E-01 |
| Normal_Weight-vs-Obese |
7.072000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.972400E-01 |
| Extreme_Weight-vs-Obese |
1.400040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.576400E-01 |
| Obese-vs-Extreme_Obese |
1.370630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.485000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.248350E-02 |
| Normal-vs-Age(61-80Yrs) |
3.87160000003828E-06 |
| Normal-vs-Age(81-100Yrs) |
2.720200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.529200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.331200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.441800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.026000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.544400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.482300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.0549000003316E-07 |
| Normal-VS-Type2 PRCC |
6.862000E-02 |
| Normal-VS-KIRP CIMP |
8.899800E-02 |
| Normal-VS-Unclassified PRCC |
2.861600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.807800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.612200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.377400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.204140E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.491200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.515600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.380050E-03 |
| Normal-vs-N1 |
2.916800E-01 |
| Normal-vs-N2 |
9.582800E-01 |
| N0-vs-N1 |
1.897000E-03 |
| N0-vs-N2 |
2.751200E-01 |
| N1-vs-N2 |
6.762400E-01 |
|
|
